Prichard et al v. Boehringer Ingeleheim Pharmaceuticals, Inc. et al

Filing 8

ORDER granting 7 Motion to Substitute Party. The motion to substitute is GRANTED. Plaintiff Joan Prichard, successor in interest to Charles Prichard, is hereby substituted in as Plaintiff for the Decedent Charles Prichard. THE COURT INSTRUCTS THE CLERK OF THE COURT TO REVISE THE DOCKET ACCORDINGLY. Signed by Chief Judge David R. Herndon on 6/12/2013. (dsw)

UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF ILLINOIS
EAST ST. LOUIS DIVISION
______________________________________________________________________________
IN RE PRADAXA
)
MDL No. 2385
(DABIGATRAN ETEXILATE) )
3:12-md-02385-DRH-SCW
PRODUCTS LIABILITY
)
Judge David R. Herndon
LITIGATION
)
______________________________________________________________________________
This Document Relates to:
Charles Prichard and Joan Prichard
v. Boehringer Ingelheim Pharmaceuticlas,
Inc. and Boehringer Ingelheim
International GmbH
No. 3:12-cv-50061-DRH-SCW
ORDER GRANTING SUBSTITUTION
HERNDON, Chief Judge:
Plaintiff Joan Prichard and her counsel, pursuant to F.R.C.P. 25(a), have
filed a motion to substitute Plaintiff Joan Prichard for Plaintiff Charles Prichard
as a result of the death of Charles Prichard (Doc. 7). Movants’ state that, pursuant
to Cal. Civ. Proc. Code §§ 377.20, 377.21 and 377.30, Plaintiff Joan Prichard, as
the wife of decedent at all times relevant to this action, has standing to bring this
claim as Plaintiff Charles Prichard’s successor in interest, as no estate has been
or will be opened, and a personal representative has not and will not be appointed
(Doc. 7).
The motion to substitute is GRANTED. Plaintiff Joan Prichard, successor
in interest to Charles Prichard, is hereby substituted in as Plaintiff for the
Decedent Charles Prichard.

FURTHER, The Court instructs the Clerk of the Court to revise the docket
accordingly.
SO ORDERED:

Digitally signed by
David R. Herndon
Date: 2013.06.12
14:48:28 -05'00'
Chief Judge
United States District Court

Date: June 12, 2013